Physical and Chemical Characterization of Aerosols Produced from Experimentally Designed Nicotine Salt-Based E-Liquids.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 8807448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5010 (Electronic) Linking ISSN: 0893228X NLM ISO Abbreviation: Chem Res Toxicol Subsets: MEDLINE

Publication: Washington Dc : American Chemical Society
Original Publication: Washington, DC : American Chemical Society, c1988-

Aerosols*/chemistry ; Nicotine*/analysis ; Nicotine*/chemistry ; Electronic Nicotine Delivery Systems*; Particle Size ; Salts/chemistry

Nicotine salt-based e-liquids deliver nicotine more rapidly and efficiently to electronic nicotine delivery system (ENDS) users than freebase nicotine formulations. Nicotine salt-based products represent a substantial majority of the United States ENDS market. Despite the popularity of nicotine salt formulations, the chemical and physical characteristics of aerosols produced by nicotine salt e-liquids are still not well understood. To address this, this study reports the harmful and potentially harmful constituents (HPHCs) and particle sizes of aerosols produced by laboratory-made freebase nicotine and nicotine salt e-liquids. The nicotine salt e-liquids were formulated with benzoic acid, citric acid, lactic acid, malic acid, or oxalic acid. The nicotine salt aerosols had different HPHC profiles than the freebase nicotine aerosols, indicating that the carboxylic acids were not innocent bystanders. The polycarboxylic acid e-liquids containing citric acid, malic acid, or oxalic acid produced higher acrolein yields than the monocarboxylic acid e-liquids containing benzoic acid or lactic acid. Across most PG:VG ratios, nicotine benzoate or nicotine lactate aerosols contained the highest nicotine quantities (in %) and the highest nicotine yields (per milligram of aerosol). Additionally, the nicotine benzoate and nicotine lactate e-liquids produced the highest carboxylic acid yields under all tested conditions. The lower acid yields of the citric, malic, and oxalic acid formulations are potentially due to a combination of factors such as lower transfer efficiencies, lower thermostabilities, and greater susceptibility to side reactions because of their additional carboxyl groups serving as new sites for reactivity. For all nicotine formulations, the particle size characteristics were primarily controlled by the e-liquid solvent ratios, and there were no clear trends between nicotine salt and freebase nicotine aerosols that indicated nicotine protonation affected particle size. The carboxylic acids impacted aerosol output, nicotine delivery, and HPHC yields in distinct ways such that interchanging them in ENDS can potentially cause downstream effects.

Nicotine Tob Res. 2014 Oct;16(10):1319-26. (PMID: 24832759)
Sci Rep. 2022 Oct 3;12(1):16497. (PMID: 36192548)
Nicotine Tob Res. 2020 Jun 12;22(7):1239-1243. (PMID: 31821492)
Drug Test Anal. 2023 Oct;15(10):1222-1232. (PMID: 36574584)
J Phys Chem A. 2006 May 11;110(18):6145-56. (PMID: 16671686)
Front Physiol. 2018 Jan 11;8:1119. (PMID: 29375395)
Expert Opin Drug Deliv. 2020 Dec;17(12):1727-1736. (PMID: 32842785)
Inhal Toxicol. 2020 May;32(6):240-248. (PMID: 32538207)
J Agric Food Chem. 1999 Dec;47(12):5133-45. (PMID: 10606585)
J Biol Chem. 1954 Mar;207(1):275-85. (PMID: 13152102)
Sci Rep. 2017 Feb 14;7:42549. (PMID: 28195231)
JAMA Netw Open. 2021 Jan 4;4(1):e2032757. (PMID: 33433597)
Food Chem Toxicol. 2018 May;115:302-305. (PMID: 29572013)
Tob Control. 2019 Mar;28(2):146-151. (PMID: 29853561)
Chem Res Toxicol. 2021 Jun 21;34(6):1640-1654. (PMID: 33949191)
Sci Rep. 2020 Apr 30;10(1):7322. (PMID: 32355323)
J Org Chem. 2019 May 17;84(10):6232-6243. (PMID: 30993995)
Sci Rep. 2021 Apr 8;11(1):7800. (PMID: 33833273)
Chem Rev. 2017 Jul 12;117(13):8864-8907. (PMID: 28266216)
Chem Res Toxicol. 2020 Oct 19;33(10):2489-2490. (PMID: 33021780)
Front Public Health. 2021 Dec 01;9:750402. (PMID: 34926374)
Sci Rep. 2020 Oct 1;10(1):16263. (PMID: 33004992)
Environ Res. 2019 Jul;174:125-134. (PMID: 31071493)
JAMA Pediatr. 2020 Jul 1;174(7):714-720. (PMID: 32478809)
Chem Res Toxicol. 2017 Aug 21;30(8):1577-1581. (PMID: 28686840)
Pharmaceuticals (Basel). 2022 Mar 17;15(3):. (PMID: 35337164)
Tob Control. 2019 Nov;28(6):678-680. (PMID: 30745326)
Tob Control. 2020 Nov;29(6):656-662. (PMID: 31848312)
Br J Clin Pharmacol. 2003 Dec;56(6):588-99. (PMID: 14616418)
Int J Environ Res Public Health. 2022 Feb 08;19(3):. (PMID: 35162914)
Inhal Toxicol. 2022;34(3-4):90-98. (PMID: 35275758)
Chem Res Toxicol. 2022 May 16;35(5):890-897. (PMID: 35512282)
Aerosol Sci Technol. 2017;51(11):1231-1239. (PMID: 32863527)
Nicotine Tob Res. 2013 Feb;15(2):501-8. (PMID: 23042984)
Int J Environ Res Public Health. 2020 Aug 05;17(16):. (PMID: 32764435)
ACS Sens. 2021 Jun 25;6(6):2403-2410. (PMID: 34081429)
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164. (PMID: 30763302)
Int J Environ Res Public Health. 2021 Jul 15;18(14):. (PMID: 34299985)
Tob Control. 2022 Sep;31(5):667-670. (PMID: 33980722)
Intern Emerg Med. 2019 Sep;14(6):853-861. (PMID: 30712148)
Aerosol Sci Technol. 2018;52(11):1233-1248. (PMID: 32773918)
Addiction. 2021 Sep;116(9):2521-2528. (PMID: 33651418)
PLoS One. 2022 Dec 20;17(12):e0279309. (PMID: 36538548)
Toxics. 2021 Dec 28;10(1):. (PMID: 35051050)
Inhal Toxicol. 2018 May;30(6):218-223. (PMID: 30257112)
Chem Res Toxicol. 2020 Feb 17;33(2):576-583. (PMID: 31950825)
Sci Rep. 2020 Nov 24;10(1):19980. (PMID: 33235307)
Environ Pollut. 2015 Jan;196:257-67. (PMID: 25463721)
Nicotine Tob Res. 2019 Aug 19;21(9):1274-1278. (PMID: 30346584)
Chem Res Toxicol. 2015 Sep 21;28(9):1675-7. (PMID: 26244921)
Tob Control. 2021 May 7;:. (PMID: 33963073)
PLoS One. 2017 Mar 08;12(3):e0173055. (PMID: 28273096)
Nicotine Tob Res. 2005 Oct;7(5):761-71. (PMID: 16191747)
Front Public Health. 2021 Aug 17;9:705099. (PMID: 34485231)
Annu Rev Anal Chem (Palo Alto Calif). 2019 Jun 12;12(1):23-39. (PMID: 30848928)
Sci Rep. 2020 Dec 10;10(1):21707. (PMID: 33303941)
Nicotine Tob Res. 2016 Sep;18(9):1895-1902. (PMID: 27146638)
Expert Opin Drug Deliv. 2021 Jul;18(7):979-989. (PMID: 33576695)
Eur J Public Health. 2012 Apr;22(2):234-7. (PMID: 21474548)
Front Toxicol. 2020 Dec 15;2:586674. (PMID: 35296117)
Aerosol Sci Technol. 2017;51(1):1-11. (PMID: 28706340)
N Engl J Med. 2019 Oct 10;381(15):1490-1491. (PMID: 31532955)
Front Public Health. 2022 Mar 17;10:782068. (PMID: 35372219)
Physiol Rep. 2019 May;7(10):e14093. (PMID: 31140749)
Tob Regul Sci. 2020 Jul;6(4):242-265. (PMID: 32789155)
PLoS One. 2018 Dec 31;13(12):e0210147. (PMID: 30596800)

0 (Aerosols)
6M3C89ZY6R (Nicotine)
0 (Salts)

Date Created: 20240730 Date Completed: 20240819 Latest Revision: 20240823

20240823

PMC11337207

10.1021/acs.chemrestox.4c00073

39078024